A clinical study of generalised peritonitis and its management in a rural setup

M. R. Shanker, M. Nahid, Prajwal S.


Background: Generalised Peritonitis is a common surgical emergency and its treatment remains a challenge despite advances in surgical techniques, antimicrobial therapy and intensive care support. The commonest etiological factors are perforation of hollow viscus and appendicitis. The aim was to study the most common cause of perforation peritonitis, associated risk factors, modes of clinical presentation, management, postoperative complications, and comorbid conditions influencing the morbidity and mortality in rural set up.

Methods: 50 patients of peritonitis of over 10 years of age managed in our institution from July 2015 to November 2016 were studied and followed up on a three-monthly basis for a period varying from 12 months to 2 years with an average of 18 months.

Results: Appendicular perforation was the most common cause of peritonitis followed by peptic ulcer perforation. Perforation peritonitis constituted 26% of total emergency operations performed with a male to female ratio of 2.84:1 and age between 41-50 years. Patients presenting within 24 hours of perforation had an uneventful recovery whereas those presenting after 24 hours had significant postoperative complications. The serum CRP levels provided as good prognostic marker. It remained high in complicated cases. Out of 56% complication rate, wound infection was the commonest.

Conclusions: Early diagnosis and surgical intervention plays a crucial role in early recovery, though the end result depends on many factors like age of the patient, degree of peritoneal contamination and presence of comorbid diseases. This study also highlights the role of CRP as a serum prognostic marker.


Appendicitis, CRP, Perforation, Peritonitis, Peptic ulcer

Full Text:



Carson H. The evolution of the modern treatment of septic peritonitis. Lancet. 1923;201(5203):1035-8.

Price M. Peritonitis, from a surgical standpoint. J Am Med Assoc. 891;17(5):173-6.

Curtis BF. The surgical treatment of peritonitis. Ann Surg. 1887;5:22-31.

Durham HE. The mechanism of reaction to peritoneal infection. J Pathol. 1897;4(3):338-82.

Steinberg B. Peritoneal exudate: a guide for the diagnosis and prognosis of peritoneal conditions. JAMA. 1941;116(7):572-8.

Pawlowsky AD. The fate of some pathogenic (primarily pyogenic) microbes when they enter the animal organism from the joints, the pleura, the eye, the oral cavity, the intestinal canal and the vagina. Medical Microbiol Immunol. 1909;62(1):433-52.

Weinberg M, Prevot AR, Davesne J, Renard C. Research on the bacteriology and serotherapy of acute appendicitis. Ann Int Pastor. 1928;42:1167-241.

Murphy JB. IV treatment of perforative peritonitis: general free suppurative. Ann Surg. 1908;47(6):870.

Kirschner M. The treatment of acute purulent free peritonitis. Arch Klin Chir. 1926;142:253-311.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Med. 1985;13(10):818-29.

Ohmann C, Yang Q, Hau T, Wacha H. Prognostic modelling in peritonitis. Peritonitis Study Group of the Surgical Infection Society Europe. Eu J Surg.1997;163(1):53-60.

Verma GR. Gastro-intestinal injuries in abdominal trauma. Trop Gastroenterol 1990;11(4):206-10.

Salvaggio MR, Pappas PG. Current concepts in the management of fungal peritonitis. Current infectious disease reports. 2003;5(2):120-4.

Wani RA, Parray FQ, Bhat NA, Wani MA, Bhat TH, Farzana F. Nontraumatic terminal ileal perforation. World J Emerg Surg. 2006;1(1):7.

Jhobta RS, Attri AK, Kaushik R, Sharma R, Jhobta A. Spectrum of perforation peritonitis in India-review of 504 consecutive cases. World J Emerg Surg. 2006;1(1):26.

Afridi S, Malik P, Ur-Rahman S, Shamim S, Samo K. Spectrum of perforation peritonitis in Pakistan: 300 cases Eastern experience. World J Emerg Surg. 2008;3(1):31.

Chakma SM, Singh RL, Parmekar MV, Singh KG, Kapa B, Sharatchandra KH, Longkumer AT. Spectrum of perforation peritonitis. J Clin Diagnostic Res: JCDR. 2013;7(11):2518-20.

Shaikh A, Shaikh SF, Shaikh SM. Common factors leading to re-laparotomy in secondary peritonitis. Rawal Med J. 2012;37(2):161-4.

Arveen S, Jagdish S, Kadambari D. Perforated peptic ulcer in South India: an institutional perspective. World J Surg. 2009;33(8):1600-4.

Noon GP, Beall AC, Jordan GL, RIGGS S, DeBakey ME. Clinical evaluation of peritoneal irrigation with antibiotic solution. Surg. 1967;62(1):73.

Khanna A, Misra M. Typhoid perforation of the gut. Postgraduate Med J. 1984;60(706):523-5.

Thirumalagiri VR, Chandra H. Acute peritonitis secondary to hollow viscous perforation: a clinical study. Int Surg J. 2017;4(7):2262-9.

Akcay I, Okoh A, Yalav O, Eray I, Rencuzogullari A, Dalci K. The prognostic value of Pro-Calcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Turkish J Trauma Emerg Surg. 2014;20(5):343-52.

Yadav D, Garg P. Spectrum of perforation peritonitis in Delhi: 77 cases experience. Indian J Surg. 2012;75(2):133-7.

Bali R, Verma S, Agarwal P, Singh R, Talwar N. Perforation peritonitis and the developing world. ISRN Surg. 2014;2014:1-4.

Ugochukwu A, Amu O, Nzegwu M, Dilibe U. Acute perforated peptic ulcer: on clinical experience in an urban tertiary hospital in south east Nigeria. Int J Surg. 2013;11(3):223-7.

Kocer B, Surmeli S, Solak C, Unal B, Bozkurt B, Yildirim O. Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol. 2007;22(4):565-70.

Tas I, Ulger B, Onder A, Kapan M, Bozdag Z. Risk factors influencing morbidity and mortality in perforated peptic ulcer disease. Turkish J Surg. 2015;31(1):20-5.

Sivaram P, Sreekumar A. Preoperative factors influencing mortality and morbidity in peptic ulcer perforation. Eu J Trauma Emerg Surg. 2017;44(2):251-7.

Unver M, Fırat Ö, Ünalp Ö, Uğuz A, Gümüş T, Sezer T, et al. Prognostic factors in peptic ulcer perforations: a retrospective 14-year study. Int Surg. 2015;100(5):942-8.

Noguiera C, Silva A, Santos J, Silva A, Ferreira J, Matos E, et al. Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg. 2003;27(7):782-7.

Reith H, Mittelkötter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med. 2000;26(15):S165-9.

Shelton J, Brown J, Young J. Preoperative C-reactive protein predicts the severity and likelihood of complications following appendicectomy. Ann Royal Coll Surg England. 2014;96(5):369-72.

Suh S, Choi Y, Park J, Kim B, Cha S, Park S, et al. Clinical factors for distinguishing perforated from nonperforated appendicitis. Surgical Laparoscopy, Endoscopy Percutaneous Tech. 2011;21(2):72-5.

Kaya B, Sana B, Eris C, Karabulut K, Bat O, Kutanis R. The Diagnostic Value of D-dimer, Procalcitonin and crp in acute appendicitis. Int J Med Sci. 2012;9(10):909-15.

Plummer JM, McFarlane ME, Newnham. Surgical management of perforated duodenal ulcer: the changing scene. West Indian Med J. 2004;53:378-81.

Boueil A, Guégan H, Colot J, D'Ortenzio E, Guerrier G. Peritoneal fluid culture and antibiotic treatment in patients with perforated appendicitis in a Pacific Island. Asian J Surg. 2015;38(4):242-6.

Ohmann C, Yang Q, Hau T, Wacha H. Prognostic modelling in peritonitis. Peritonitis study group of the surgical infection society Europe. Eu J Surg.1997;163(1):53-60.

Chalya P, Mabula J, Koy M, Mchembe M, Jaka H, Kabangila R, et al. Clinical profile and outcome of surgical treatment of perforated peptic ulcers in north western tanzania: a tertiary hospital experience. World J Emerg Surg. 2011;6(1):31.

Montalvo-Javé EE, Corres-Sillas O, Athié-Gutiérrez C. Factors associated with postoperative complications and mortality in perforated peptic ulcer. Cirugia Y Cirujanos. 2011;79(2):141-8.